Histotripsy May Expand Beyond Liver Tumors, but Long-Term Data Are Still Needed
Histotripsy uses ultrasound to destroy liver tumors, but more long-term data on recurrence and survival are needed to confirm its effectiveness.
Shaun P. McKenzie, MD, FACS, a surgical oncologist with Texas Oncology, explained that histotripsy, a novel technique using high-frequency ultrasound waves to destroy tumors, is currently used in the liver due to its durability and experience with ablative therapy. While histotripsy shows promise in destroying liver tumors, longer-term data on recurrence rates and overall survival are still needed to fully assess its effectiveness.
Read the full story in American Journal of Managed Care.